← Leaderboards
Matthew Boxer
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesPharmaceutical ChemistryPublicationsResearch PersonnelInformaticsNovel TherapeuticsDrug DevelopmentExtramural ActivitiesPharmaceutical PreparationsNew TechnologyHuman DiseaseBiologyLeadInhibitor/AntagonistCollaborationsCommunitiesAssay DevelopmentDrug DiscoveryBaseGenomicsGeneral PopulationFosteringHigh Throughput ScreeningScreening
Grant awards (19)
qHTS to Identify Inhibitors of USP12$226,982
ZIA · FY2016 · TR · contact PI
Advanced development of human mutant IDH1 inhibitors (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)$226,982
ZIA · FY2016 · TR · contact PI
Identification of Inhibitors of the Lipid Kinase PI5P4Ka/B as Potential Anti-Cancer Agents$226,982
ZIA · FY2016 · TR · contact PI
Identification of USP2 Inhibitors$226,982
ZIA · FY2016 · TR · contact PI
Characterization of inhibitors of human mutant IDH1$226,982
ZIA · FY2016 · TR · contact PI
Identification of Inhibitors of human Galactokinase (GALK) for the treatment of Galactosemia$226,982
ZIA · FY2016 · TR · contact PI
Identification of Inhibitors of Nrf2 Expression$226,982
ZIA · FY2016 · TR · contact PI
Identification of Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)$226,982
ZIA · FY2016 · TR · contact PI
qHTS to Identify Inhibitors of DYT1 Inclusion Formation$37,474
ZIA · FY2016 · TR · contact PI
qHTS to Identify Inhibitors of USP12$114,000
ZIA · FY2015 · TR · contact PI
Identification of Inhibitors of the Lipid Kinase PI5P4Ka/ as Potential Anti-Cancer Agents$114,000
ZIA · FY2015 · TR · contact PI
Identification of USP2 Inhibitors$114,000
ZIA · FY2015 · TR · contact PI
Identification of Inhibitors of IDH1 R132H$114,000
ZIA · FY2015 · TR · contact PI
Identification of Inhibitors of human Galactokinase (GALK) for the treatment of Galactosemia$114,000
ZIA · FY2015 · TR · contact PI
Identification of Modulators of Lipid Storage$114,000
ZIA · FY2015 · TR · contact PI
Identification of Inhibitors of Nrf2 Expression$114,000
ZIA · FY2015 · TR · contact PI
Identification of Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)$114,000
ZIA · FY2015 · TR · contact PI
qHTS to Identify Inhibitors of DYT1 Inclusion Formation$19,000
ZIA · FY2015 · TR · contact PI
qHTS to Identify Activators and Inhibitors of Wip1$19,000
ZIA · FY2015 · TR · contact PI